[L-Asparaginase in the treatment of acute leukemia].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D001215:Asparaginase / Q000008:administration & dosage* / Q000009:adverse effects; D002675:Child, Preschool; D004342:Drug Hypersensitivity / Q000209:etiology; D004361:Drug Tolerance; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents; D007223:Infant; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000276:immunology; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000276:immunology; D007970:Leukopenia / Q000139:chemically induced; D008111:Liver Function Tests; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D007166:Immunosuppressive Agents; D014750:Vincristine; D001215:Asparaginase; D011241:Prednisone; D008727:Methotrexate
La L-asparaginase dans le traitement des leucémies aiguës.